Buscar
Mostrando ítems 1-10 de 28540
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
(BioMed Central, 2017)
BACKGROUND:
Immunostimulatory therapies targeting immune-suppressive pathways produce durable responses in advanced solid tumors. Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting oxidoreductase that catalyzes the ...
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
(BioMed Central, 2017)
BACKGROUND:
Immunostimulatory therapies targeting immune-suppressive pathways produce durable responses in advanced solid tumors. Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting oxidoreductase that catalyzes the ...
Indoleamine 2,3-dioxygenase (IDO) Activity in Placental Compartments of Renal-Transplanted Pregnant Women
(Wiley-Blackwell, 2014-07-01)
Problem Immunosuppressive drugs change gestational IDO activity at the maternal-fetal interface. Method of Study Analysis of placental IDO expression and activity, interferon gamma (IFN-), and IL-10 expression and NFkB ...
IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
(Karger, 2014-07)
Indoleamine-2,3-dioxygenase (IDO) has been established as a normal mechanism of peripheral tolerance and immunosuppression. Besides, malignant tumors release microvesicles (MV) related with tumor dissemination. The aims ...
Idos Corp
(2014)
Idos Corp
(2014)
Idos Corp
(2014)
Idos Corp
(2014)